Description

SUHAGRA 100 MG (1X4)

Indications

SUHAGRA 100 MG is primarily indicated for the treatment of erectile dysfunction (ED) in adult men. Erectile dysfunction is a condition characterized by the inability to achieve or maintain an erection sufficient for satisfactory sexual performance. SUHAGRA contains the active ingredient Sildenafil Citrate, which is a phosphodiesterase type 5 (PDE5) inhibitor. This medication is prescribed when a patient is experiencing difficulties in achieving or sustaining an erection, which can be due to various physiological or psychological factors.

Mechanism of Action

The active component of SUHAGRA, Sildenafil Citrate, works by inhibiting the phosphodiesterase type 5 enzyme. This enzyme is responsible for the degradation of cyclic guanosine monophosphate (cGMP), a molecule that plays a crucial role in the relaxation of smooth muscle and vasodilation in the corpus cavernosum of the penis. When sexual stimulation occurs, nitric oxide is released, leading to an increase in cGMP levels. By inhibiting PDE5, SUHAGRA enhances the effects of nitric oxide, resulting in increased blood flow to the penis and facilitating an erection in response to sexual arousal.

Pharmacological Properties

Sildenafil Citrate is rapidly absorbed after oral administration, with peak plasma concentrations typically occurring within 30 to 120 minutes. The bioavailability of the drug is approximately 40%, and its effects can last for up to four hours, although this may vary depending on individual factors such as metabolism and overall health. The drug is primarily metabolized in the liver by cytochrome P450 enzymes, particularly CYP3A4, and is excreted predominantly in the feces, with a smaller portion eliminated through urine.

Contraindications

SUHAGRA should not be used in individuals who are hypersensitive to Sildenafil Citrate or any of the excipients in the formulation. It is contraindicated in patients who are currently taking nitrates in any form, as the combination can lead to a significant drop in blood pressure. Additionally, it should not be used in individuals with severe cardiovascular disorders, such as unstable angina or severe hypotension, as sexual activity poses a potential risk for these patients.

Side Effects

Common side effects associated with the use of SUHAGRA include headache, flushing, dyspepsia, nasal congestion, and visual disturbances such as changes in color perception. Less commonly, patients may experience dizziness, palpitations, or priapism, a prolonged and painful erection that requires immediate medical attention. Serious side effects, though rare, can include myocardial infarction, stroke, and sudden hearing loss. Patients are advised to seek medical help if they experience any severe or persistent side effects.

Dosage and Administration

The recommended starting dose of SUHAGRA for most patients is 50 mg, taken approximately one hour before sexual activity. Depending on efficacy and tolerability, the dose may be adjusted to a maximum of 100 mg or decreased to 25 mg. It is important to note that SUHAGRA should not be taken more than once a day. The medication can be taken with or without food, although a high-fat meal may delay the onset of action. Patients should follow their healthcare provider’s instructions regarding dosage and administration to ensure optimal results.

Interactions

SUHAGRA can interact with various medications, which may enhance the risk of side effects or reduce the effectiveness of the drug. Co-administration with nitrates or nitric oxide donors can lead to severe hypotension. Other medications that may interact with Sildenafil include certain antihypertensives, alpha-blockers, and protease inhibitors. It is essential for patients to inform their healthcare provider about all medications they are taking, including over-the-counter drugs and herbal supplements, to avoid potential interactions.

Precautions

Before starting treatment with SUHAGRA, patients should undergo a thorough medical evaluation to rule out any underlying health issues that may contribute to erectile dysfunction. Special caution should be exercised in patients with a history of cardiovascular disease, renal impairment, or liver dysfunction, as these conditions may affect the metabolism and clearance of the drug. Patients should also be advised to avoid excessive alcohol consumption, as this can impair the ability to achieve an erection and increase the risk of side effects.

Clinical Studies

Numerous clinical studies have demonstrated the efficacy and safety of Sildenafil Citrate in the treatment of erectile dysfunction. In a randomized, double-blind, placebo-controlled trial, men with ED reported significant improvements in their ability to achieve and maintain an erection when treated with Sildenafil compared to those receiving a placebo. The studies have shown that the medication is effective across various age groups and etiologies of erectile dysfunction, including those with diabetes and post-prostatectomy patients. Long-term studies have also indicated a favorable safety profile, with most side effects being mild to moderate in severity.

Conclusion

SUHAGRA 100 MG is a well-established treatment option for erectile dysfunction, offering men the opportunity to regain their sexual function and improve their quality of life. With its proven mechanism of action and extensive clinical support, it is a reliable choice for those experiencing difficulties in achieving or maintaining an erection. Patients should consult with their healthcare provider to determine if SUHAGRA is appropriate for their specific situation and to receive guidance on proper usage.